Sign Out
Adults: Ondansetron Kabi is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. Ondansetron Kabi is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV).
Paediatric Population: Ondansetron Kabi is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged ≥6 months, and for the prevention and treatment of PONV in children aged ≥1 month.
